Myasthenia gravis: Pathogenesis and treatment

David P Richman, M. A. Agius

Research output: Contribution to journalArticle

15 Scopus citations

Abstract

Much is known about the pathogenesis of MG. This information has provided a rational basis for treatment of the disease, which is very effective. On the other hand, present treatments are limited by significant adverse effects. Our knowledge of pathogenesis also provides clues for the development of new, effective, but less toxic treatments. In addition, knowledge of the autoimmune mechanisms in MG may be useful in devising better treatments for the many human autoimmune diseases that are less well understood.

Original languageEnglish (US)
Pages (from-to)106-110
Number of pages5
JournalSeminars in Neurology
Volume14
Issue number2
StatePublished - 1994

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Fingerprint Dive into the research topics of 'Myasthenia gravis: Pathogenesis and treatment'. Together they form a unique fingerprint.

  • Cite this